Related by context. Frequent words. (Click for all words.) 65 Completes Enrollment 62 Phase III Trial 61 Monotherapy 60 Drug Candidate 59 FDA Approves 58 Tolerability 57 Non Invasive 57 Combination Therapy 56 Postmenopausal Women 56 Coronary Stent 55 Relapsed 54 Initiates Phase 54 Gemcitabine 54 Pharmacokinetic 54 Bevacizumab 53 Percutaneous 53 Efficacy 53 Nasal Spray 52 FOLFIRI 52 Rivaroxaban 52 serum phosphorus 51 Rosuvastatin 50 LIALDA 50 peginterferon alfa 2b 50 Clinical Study 49 decitabine 49 Prophylactic 49 Dexamethasone 49 tocilizumab 49 Ezetimibe 48 Taxotere R 48 Prophylaxis 48 Lantus R 48 Clopidogrel 48 Secondary endpoints 48 plus methotrexate 48 Endpoints 47 Randomized 47 Ribavirin 47 dose regimens 47 Pharmacokinetics 46 non inferiority 46 Adjuvant 46 Cost Effectiveness 46 Phase 1b trial 46 mg BID 46 Olanzapine 46 FOLFOX 45 bosentan 45 tiotropium 45 Methotrexate 45 lopinavir ritonavir 45 azacitidine 45 ziprasidone 45 multicenter randomized double 45 randomized controlled clinical 45 adalimumab 45 mcg kg 44 Secondary endpoints include 44 lacosamide 44 Myocardial Infarction 44 efficacy endpoints 43 aripiprazole 43 SPIRIT III 43 noninferiority 42 double blind placebo 42 pharmacodynamic 42 tolerability 42 randomized double 42 Clinical Trial 42 demonstrated statistically significant 42 blind randomized placebo 41 certolizumab pegol 41 plus ribavirin 41 Pharmacological 41 statistically significant improvement 41 secondary endpoints 40 tolerated dose MTD 40 tolerability profile 40 prospective randomized 40 pharmacokinetic profile 40 monotherapy 40 pioglitazone 40 efficacy 39 Phase 1b 39 etanercept 38 Effectiveness 38 placebo controlled 38 placebo controlled trials 38 randomized 38 prespecified 37 pharmacokinetic 37 antiviral activity 37 mg dose 37 TMC# [001] 36 multicenter 36 randomized placebo controlled 35 randomized clinical 35 immunogenicity 33 Abstract # 33 randomized trials